Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease

Background: We investigated how the non-medical switching (NMS) between Etanercept (ETN)/originator and SB4/biosimilar affects treatment efficacy in a rheumatic disease (RD) cohort, evaluating some laboratory parameters as loss of efficacy predictors after NMS. Methods: We enrolled 124 patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Benucci, Maurizio, Damiani, Arianna, Russo, Edda, Li Gobbi, Francesca, Grossi, Valentina, Amedei, Amedeo, Infantino, Maria, Manfredi, Mariangela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316161/
https://www.ncbi.nlm.nih.gov/pubmed/35887671
http://dx.doi.org/10.3390/jpm12071174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316161/
https://www.ncbi.nlm.nih.gov/pubmed/35887671
http://dx.doi.org/10.3390/jpm12071174

Ejemplares similares